08.01.2021 • NewsSolvay

Solvay Sells Surfactants to OpenGate Capital

Solvay’s transformation to a specialties company has taken another step forward with an agreement to sell its European and North American amphoteric surfactant business to US private equity firm OpenGate Capital.

The business, which employs about 175 people, is a key player in surfactants, with a focus on producing amphoterics primarily used in body care, hair care and home care products.

The sale includes three main production sites in Genthin, Germany, Halifax, UK, and University Park, Illinois, USA, as well as a tolling business in Turkey. It also includes tolling and service agreements with OpenGate “to ensure a seamless transition and minimal customer disruption.”

“This agreement represents another critical step in the execution of our strategic plan as we further focus our home & personal care portfolio on growing specialty formulations and custom solutions,” said Michael Radossich, president of Solvay's Novecare global business unit.

The transaction is expected to close by end March, pending completion of customary conditions and regulatory approvals.

Solvay said it will invest the proceeds of the sale in its strategic growth segments “as part of its portfolio simplification journey.”

Last November, Solvay agreed to sell its barium and strontium business in Germany, Spain and Mexico, as well as its sodium percarbonate business in Germany, to Latour Capital. Earlier that month, the Belgian group also revealed it was negotiating the sale of its process materials business with Composites One.

On Jan. 31, 2020, Solvay completed the sale of its performance polyamide activities to BASF and Domo Chemicals.

Author: Elaine Burridge, Freelance Journalist

Solvay has agreed to sell its European and North American amphoteric surfactant...
Solvay has agreed to sell its European and North American amphoteric surfactant business to OpenGate Capital. The sale includes three main production sites in Genthin, Germany, Halifax, UK, and University Park, Illinois, USA, as well as a tolling business in Turkey. (c) Solvay

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read